BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $9,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $9,000 | +12.5% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $8,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | -20.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2015 | $10,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2015 | $10,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2015 | $12,000 | +9.1% | 2,000 | 0.0% | 0.00% | – |
| Q1 2015 | $11,000 | +37.5% | 2,000 | 0.0% | 0.00% | – |
| Q4 2014 | $8,000 | +14.3% | 2,000 | 0.0% | 0.00% | – |
| Q3 2014 | $7,000 | +16.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2014 | $6,000 | -14.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2014 | $7,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2013 | $7,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2013 | $7,000 | +16.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2013 | $6,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ANGELO GORDON & CO., L.P. | 7,047,000 | $24,506,000 | 1.92% |
| Baker Brothers Advisors | 22,898,000 | $79,367,000 | 1.12% |
| Amici Capital, LLC | 8,000,000 | $27,840,000 | 0.88% |
| RWC Asset Management LLP | 2,000,000 | $6,964,000 | 0.74% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $37,000 | 0.04% |
| CITIGROUP INC | 6,262,000 | $21,776,000 | 0.02% |
| LORD, ABBETT & CO. LLC | 2,390,000 | $8,317,000 | 0.02% |
| SG Americas Securities, LLC | 10,000 | $3,480,000 | 0.01% |
| DEUTSCHE BANK AG\ | 5,000,000 | $17,385,000 | 0.01% |
| SSI INVESTMENT MANAGEMENT LLC | 27,000 | $93,000 | 0.01% |